GLP-1 (7¿36) amide restores myocardial insulin sensitivity and prevents the progression of heart failure in senescent beagles

Background: We previously demonstrated that older beagles have impaired whole body and myocardial insulin responsiveness (MIR), and that glucagon-like peptide-1 (GLP-1 [7?36] amide) improves MIR in young beagles with dilated cardiomyopathy (DCM). Here, we sought to determine if aging alone predisposes to an accelerated course of DCM, and if GLP-1 [7?36] amide would restore MIR and impact the course of DCM in older beagles. Methods: Eight young beagles (Young-Control) and sixteen old beagles underwent chronic left ventricle (LV) instrumentation. Seven old beagles were treated with GLP-1 (7?36) amide (2.5pmol/kg/min) for 2?weeks prior to instrumentation and for 35?days thereafter (Old?+?GLP-1), while other 9 served as control (Old-Control). All dogs underwent baseline metabolic determinations and LV biopsy for mitochondria isolation prior to the development of DCM induced by rapid pacing (240?min?1). Hemodynamic measurements were performed routinely as heart failure progressed. Results: At baseline, all old beagles had elevated non-esterifed fatty acids (NEFA), and impaired MIR. GLP-1 reduced plasma NEFA (Old-Control: 853???34; Old?+?GLP-1: 531???33??mol/L, p?
Source: Cardiovascular Diabetology - Category: Cardiology Authors: Source Type: research